X-118974848-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000371628.8(LONRF3):c.68C>T(p.Ser23Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,206,679 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000371628.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LONRF3 | NM_001031855.3 | c.68C>T | p.Ser23Leu | missense_variant | 1/11 | ENST00000371628.8 | NP_001027026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LONRF3 | ENST00000371628.8 | c.68C>T | p.Ser23Leu | missense_variant | 1/11 | 1 | NM_001031855.3 | ENSP00000360690.3 | ||
LONRF3 | ENST00000304778.11 | c.68C>T | p.Ser23Leu | missense_variant | 1/10 | 1 | ENSP00000307732.7 | |||
LONRF3 | ENST00000481285.5 | n.68C>T | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000435426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000886 AC: 10AN: 112846Hom.: 0 Cov.: 24 AF XY: 0.0000571 AC XY: 2AN XY: 35000
GnomAD3 exomes AF: 0.0000596 AC: 10AN: 167778Hom.: 0 AF XY: 0.0000350 AC XY: 2AN XY: 57094
GnomAD4 exome AF: 0.0000110 AC: 12AN: 1093833Hom.: 0 Cov.: 33 AF XY: 0.0000139 AC XY: 5AN XY: 360137
GnomAD4 genome AF: 0.0000886 AC: 10AN: 112846Hom.: 0 Cov.: 24 AF XY: 0.0000571 AC XY: 2AN XY: 35000
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at